FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:DNM2-CNN1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: DNM2-CNN1
FusionPDB ID: 23639
FusionGDB2.0 ID: 23639
HgeneTgene
Gene symbol

DNM2

CNN1

Gene ID

1785

1264

Gene namedynamin 2calponin 1
SynonymsCMT2M|CMTDI1|CMTDIB|DI-CMTB|DYN2|DYNII|LCCS5HEL-S-14|SMCC|Sm-Calp
Cytomap

19p13.2

19p13.2

Type of geneprotein-codingprotein-coding
Descriptiondynamin-2dynamin IIcalponin-1basic calponincalponin 1, basic, smooth musclecalponin H1, smooth musclecalponins, basicepididymis secretory protein Li 14
Modification date2020032920200313
UniProtAcc

P50570

Main function of 5'-partner protein: FUNCTION: Microtubule-associated force-producing protein involved in producing microtubule bundles and able to bind and hydrolyze GTP. Plays a role in the regulation of neuron morphology, axon growth and formation of neuronal growth cones (By similarity). Plays an important role in vesicular trafficking processes, in particular endocytosis. Involved in cytokinesis (PubMed:12498685). Regulates maturation of apoptotic cell corpse-containing phagosomes by recruiting PIK3C3 to the phagosome membrane (By similarity). {ECO:0000250|UniProtKB:P39052, ECO:0000250|UniProtKB:P39054, ECO:0000269|PubMed:12498685}.

P51911

Main function of 5'-partner protein: FUNCTION: Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity (By similarity). {ECO:0000250}.
Ensembl transtripts involved in fusion geneENST idsENST00000314646, ENST00000355667, 
ENST00000359692, ENST00000389253, 
ENST00000408974, ENST00000585892, 
ENST00000591819, 
ENST00000544952, 
ENST00000588468, ENST00000252456, 
ENST00000535659, ENST00000592923, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score36 X 17 X 17=104044 X 3 X 3=36
# samples 495
** MAII scorelog2(49/10404*10)=-4.40821274494042
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/36*10)=0.473931188332412
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: DNM2 [Title/Abstract] AND CNN1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: DNM2 [Title/Abstract] AND CNN1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)DNM2(10934575)-CNN1(11649701), # samples:1
DNM2(10934575)-CNN1(11651891), # samples:1
Anticipated loss of major functional domain due to fusion event.DNM2-CNN1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DNM2-CNN1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DNM2-CNN1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
DNM2-CNN1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneDNM2

GO:1903526

negative regulation of membrane tubulation

18388313



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:10934575/chr19:11649701)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across DNM2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across CNN1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000585892DNM2chr1910934575+ENST00000252456CNN1chr1911651891+341620571642887907
ENST00000314646DNM2chr1910934575+ENST00000252456CNN1chr1911651891+341620571642887907
ENST00000359692DNM2chr1910934575+ENST00000252456CNN1chr1911651891+339020311502861903
ENST00000389253DNM2chr1910934575+ENST00000252456CNN1chr1911651891+336420051122835907
ENST00000355667DNM2chr1910934575+ENST00000252456CNN1chr1911651891+33321973802803907
ENST00000408974DNM2chr1910934575+ENST00000252456CNN1chr1911651891+32751916352746903

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000585892ENST00000252456DNM2chr1910934575+CNN1chr1911651891+0.011517120.9884829
ENST00000314646ENST00000252456DNM2chr1910934575+CNN1chr1911651891+0.0113775860.9886225
ENST00000359692ENST00000252456DNM2chr1910934575+CNN1chr1911651891+0.0113377760.9886622
ENST00000389253ENST00000252456DNM2chr1910934575+CNN1chr1911651891+0.010865220.9891348
ENST00000355667ENST00000252456DNM2chr1910934575+CNN1chr1911651891+0.0112599780.98874
ENST00000408974ENST00000252456DNM2chr1910934575+CNN1chr1911651891+0.0115597020.9884403

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for DNM2-CNN1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
DNM2chr1910934575CNN1chr19116518911916396LRREISYAIKNIHGVRTGLFTPDMAF
DNM2chr1910934575CNN1chr19116518911973398REISYAIKNIHGVRTGLFTPDLAFEA
DNM2chr1910934575CNN1chr19116518912005396LRREISYAIKNIHGVRTGLFTPDMAF
DNM2chr1910934575CNN1chr19116518912031398REISYAIKNIHGVRTGLFTPDLAFEA
DNM2chr1910934575CNN1chr19116518912057396LRREISYAIKNIHGVRTGLFTPDMAF
DNM2chr1910934575CNN1chr19116518912057398REISYAIKNIHGVRTGLFTPDLAFEA

Top

Potential FusionNeoAntigen Information of DNM2-CNN1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DNM2-CNN1_10934575_11651891.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DNM2-CNN1chr1910934575chr19116518911973HLA-A31:02AIKNIHGVR0.9230.8665514
DNM2-CNN1chr1910934575chr19116518911973HLA-A31:06AIKNIHGVR0.88060.713514
DNM2-CNN1chr1910934575chr19116518911973HLA-A31:01AIKNIHGVR0.970.8489514

Top

Potential FusionNeoAntigen Information of DNM2-CNN1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DNM2-CNN1_10934575_11651891.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DNM2-CNN1chr1910934575chr19116518912057DRB1-0804RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0807EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-0807REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518912057DRB1-0807RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518911973DRB1-0807EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-0807REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-0808EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518911973DRB1-0808EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0811EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518911973DRB1-0811EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0813EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518911973DRB1-0813EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0815EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-0815REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518912057DRB1-0815RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518911973DRB1-0815EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-0815REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-0819EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518911973DRB1-0819EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0820RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0822RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0825IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-0825IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-0830EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-0830REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518912057DRB1-0830RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518911973DRB1-0830EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-0830REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-0831RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0834EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518911973DRB1-0834EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518912057DRB1-0906IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-0906IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1103RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1104RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1106RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1117RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1118RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1125RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1134RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1135RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1138RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1141RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1142RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1143RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1144RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1145EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-1145RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518911973DRB1-1145EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1146RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1147RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1148RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1150RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1152RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1154RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1154LRREISYAIKNIHGV015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1156RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1157RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1158RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1159RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1160RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1163RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1176RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1177RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1178RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1183RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1184RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1185RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1188RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1189RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1189LRREISYAIKNIHGV015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1192RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1201IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1201IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1203IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1203IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1205IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1205IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1206IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1206IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1207IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1207IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1208IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518912057DRB1-1208AIKNIHGVRTGLFTP722
DNM2-CNN1chr1910934575chr19116518911973DRB1-1208IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518911973DRB1-1208AIKNIHGVRTGLFTP520
DNM2-CNN1chr1910934575chr19116518912057DRB1-1210IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1210IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1211IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1211IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1212IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1212IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1213IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1213IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1214IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1214IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1215IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1215IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1217IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1217IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1218IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1218IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1219IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1219IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1220IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1220IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1221IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518912057DRB1-1221AIKNIHGVRTGLFTP722
DNM2-CNN1chr1910934575chr19116518911973DRB1-1221IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518911973DRB1-1221AIKNIHGVRTGLFTP520
DNM2-CNN1chr1910934575chr19116518912057DRB1-1223IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1223IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1306RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1308RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1309RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1311RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1318RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1319RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1324RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1342RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1344RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1353RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1367EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-1367REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518912057DRB1-1367RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518911973DRB1-1367EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-1367REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1370RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1372RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1375RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1376RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1376LRREISYAIKNIHGV015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1377IKNIHGVRTGLFTPD823
DNM2-CNN1chr1910934575chr19116518911973DRB1-1377IKNIHGVRTGLFTPD621
DNM2-CNN1chr1910934575chr19116518912057DRB1-1384RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1385RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1403RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1403EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-1403REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518911973DRB1-1403EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-1403REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1405RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1406RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1408RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1411RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1411LRREISYAIKNIHGV015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1412RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1415RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1417RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1418RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1418LRREISYAIKNIHGV015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1420RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1421RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1423RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1424RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1427RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1427EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518911973DRB1-1427EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1429RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1433RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1434RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1437RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1440RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1440EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-1440REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518911973DRB1-1440EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-1440REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1443RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1445RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1445LRREISYAIKNIHGV015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1451RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1456RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1459RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1463RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1463REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518911973DRB1-1463REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1464RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1467RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1467EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-1467REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518911973DRB1-1467EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-1467REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1472RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1473RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1477RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1477EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-1477REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518911973DRB1-1477EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-1477REISYAIKNIHGVRT015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1478RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1480RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1481RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1483RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1484RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1485RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1489RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1491RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1495RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1495LRREISYAIKNIHGV015
DNM2-CNN1chr1910934575chr19116518912057DRB1-1496RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1498RREISYAIKNIHGVR116
DNM2-CNN1chr1910934575chr19116518912057DRB1-1498EISYAIKNIHGVRTG318
DNM2-CNN1chr1910934575chr19116518912057DRB1-1498REISYAIKNIHGVRT217
DNM2-CNN1chr1910934575chr19116518911973DRB1-1498EISYAIKNIHGVRTG116
DNM2-CNN1chr1910934575chr19116518911973DRB1-1498REISYAIKNIHGVRT015

Top

Fusion breakpoint peptide structures of DNM2-CNN1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3768IKNIHGVRTGLFTPDNM2CNN1chr1910934575chr19116518911973

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of DNM2-CNN1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3768IKNIHGVRTGLFTP-7.15543-7.26883
HLA-B14:023BVN3768IKNIHGVRTGLFTP-4.77435-5.80965
HLA-B52:013W393768IKNIHGVRTGLFTP-6.80875-6.92215
HLA-B52:013W393768IKNIHGVRTGLFTP-4.20386-5.23916
HLA-A11:014UQ23768IKNIHGVRTGLFTP-7.5194-8.5547
HLA-A11:014UQ23768IKNIHGVRTGLFTP-6.9601-7.0735
HLA-A24:025HGA3768IKNIHGVRTGLFTP-7.52403-7.63743
HLA-A24:025HGA3768IKNIHGVRTGLFTP-5.82433-6.85963
HLA-B27:056PYJ3768IKNIHGVRTGLFTP-3.28285-4.31815
HLA-B44:053DX83768IKNIHGVRTGLFTP-5.91172-6.94702
HLA-B44:053DX83768IKNIHGVRTGLFTP-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of DNM2-CNN1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
DNM2-CNN1chr1910934575chr1911651891514AIKNIHGVRGGCGTCTACCCCGAGAAGGACCAGCTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
DNM2-CNN1chr1910934575chr1911651891015LRREISYAIKNIHGVTCGTTCCTCCGAGCTGGCGTCTACCCCGAGAAGGACCAGCTGGCC
DNM2-CNN1chr1910934575chr1911651891015REISYAIKNIHGVRTTCGTTCCTCCGAGCTGGCGTCTACCCCGAGAAGGACCAGCTGGCC
DNM2-CNN1chr1910934575chr1911651891116EISYAIKNIHGVRTGTTCCTCCGAGCTGGCGTCTACCCCGAGAAGGACCAGCTGGCCCAG
DNM2-CNN1chr1910934575chr1911651891116RREISYAIKNIHGVRTTCCTCCGAGCTGGCGTCTACCCCGAGAAGGACCAGCTGGCCCAG
DNM2-CNN1chr1910934575chr1911651891217REISYAIKNIHGVRTCTCCGAGCTGGCGTCTACCCCGAGAAGGACCAGCTGGCCCAGAAG
DNM2-CNN1chr1910934575chr1911651891318EISYAIKNIHGVRTGCGAGCTGGCGTCTACCCCGAGAAGGACCAGCTGGCCCAGAAGTAT
DNM2-CNN1chr1910934575chr1911651891520AIKNIHGVRTGLFTPGGCGTCTACCCCGAGAAGGACCAGCTGGCCCAGAAGTATGACCAC
DNM2-CNN1chr1910934575chr1911651891621IKNIHGVRTGLFTPDGTCTACCCCGAGAAGGACCAGCTGGCCCAGAAGTATGACCACCAG
DNM2-CNN1chr1910934575chr1911651891722AIKNIHGVRTGLFTPTACCCCGAGAAGGACCAGCTGGCCCAGAAGTATGACCACCAGCGG
DNM2-CNN1chr1910934575chr1911651891823IKNIHGVRTGLFTPDCCCGAGAAGGACCAGCTGGCCCAGAAGTATGACCACCAGCGGGAG

Top

Information of the samples that have these potential fusion neoantigens of DNM2-CNN1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
COADDNM2-CNN1chr1910934575ENST00000355667chr1911651891ENST00000252456TCGA-AA-3666-01A

Top

Potential target of CAR-T therapy development for DNM2-CNN1

check button Predicted 3D structure. We used RoseTTAFold.
143_DNM2-CNN1_t000_.e2e.pdb


check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result
DNM2chr1910934575ENST00000314646CNN1chr1911651891ENST00000252456
DNM2chr1910934575ENST00000355667CNN1chr1911651891ENST00000252456
DNM2chr1910934575ENST00000359692CNN1chr1911651891ENST00000252456
DNM2chr1910934575ENST00000389253CNN1chr1911651891ENST00000252456
DNM2chr1910934575ENST00000408974CNN1chr1911651891ENST00000252456

Top

Related Drugs to DNM2-CNN1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to DNM2-CNN1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource